NCT00577122 2023-10-16
Medroxyprogesterone +/- Cyclophosphamide & Methotrexate in Hormone Receptor-Negative Recurrent/Metastatic Breast Cancer
Indiana University
Phase 2 Completed
Indiana University
National Cancer Institute (NCI)
Yale University
University of Illinois at Chicago
Prisma Health-Upstate
GOG Foundation